Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, announced that the final data analysis from its Phase II study of Namodenoson in the treatment of patients with non-alcoholic fatty liver disease with or without non-alcoholic steatohepatitis has been completed.


Go to Source

Start Free Trial: Database Active Pharma Ingredients Manufacturers

– API Database contains 43 000 generic API listed with price ranges. Including regulatory information, price ranges US market, EU, Canada, and other regulated markets and rest of the world.

– A list of more than 5000 verified API vendors.
including DMF’s availability, Purity, CEP, FDF dossier availability, contact details/ Distributors/branch, etc.

– A list of Pharmaceutical Excipients Vendors
including regulatory information, price ranges, contact details, etc.

– Pharmaceutical dossiers for sale and Impurity Standards. List of owners and contact details.

You can cancel your subscription anytime.